LakeShore Biopharma Co Ltd
LSBPW0.027USD
-0.007-22.16%
Market hours （ET）Quotes delayed by 15 min
0.00Market Cap
--P/E TTM
More Details of LakeShore Biopharma Co Ltd Company
LakeShore Biopharma Co Ltd, formerly YS Biopharma Co Ltd, is a biopharmaceutical company dedicated to discovering, developing, manufacturing and commercializing new generations of vaccines and therapeutic biologics for infectious diseases and cancer. The Company's vaccine product YSJATM rabies vaccine has been commercialized. The Company also has four product candidates under various clinical development stages, including PIKA rabies vaccine, PIKA recombinant COVID-19 vaccine, PIKA YS-ON-001 and PIKA YS-HBV-001, and four preclinical stage product candidates, targeting HBV, influenza and cancer with enormous medical demand. In addition, the Company is working on a series of therapeutic targets, rabies and products at the discovery stage.
Company Info
Ticker SymbolLSBPW
Company nameLakeShore Biopharma Co Ltd
IPO dateJul 30, 2021
CEOMr. Dave Chenn
Number of employees- -
Security typeCompany Warrant
Fiscal year-end- -
Address- -
City- -
Stock exchangeNASDAQ Capital Market Consolidated
Country- -
Postal code- -
Phone- -
Website- -
Ticker SymbolLSBPW
IPO dateJul 30, 2021
CEOMr. Dave Chenn
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Dr. Viren Mehta
Dr. Viren Mehta
Independent Director
Independent Director
--
--
Ms. Zengjun Xu
Ms. Zengjun Xu
Director
Director
--
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
--
--
Mr. Adam Zhao
Mr. Adam Zhao
Director
Director
--
--
Mr. Shaojing Tong
Mr. Shaojing Tong
Independent Director
Independent Director
--
--
Dr. Stanley Yi Chang
Dr. Stanley Yi Chang
Independent Director
Independent Director
--
--
Dr. Yuan Liu
Dr. Yuan Liu
Head of vaccine research
Head of vaccine research
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Gang Li
Mr. Gang Li
Head of Marketing and sales
Head of Marketing and sales
--
--
Mr. Chunyang Shao
Mr. Chunyang Shao
Director
Director
--
--
Dr. Viren Mehta
Dr. Viren Mehta
Independent Director
Independent Director
--
--
Ms. Zengjun Xu
Ms. Zengjun Xu
Director
Director
--
--
Ms. Chunyuan Wu
Ms. Chunyuan Wu
Chief Financial Officer
Chief Financial Officer
--
--
Mr. Dave Chenn
Mr. Dave Chenn
Interim Co-Chief Executive Officer, Director
Interim Co-Chief Executive Officer, Director
--
--
Revenue Breakdown
No Data
No Data
By Business
By Region
No Data
Shareholding Stats
Updated: Fri, May 16
Updated: Fri, May 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholders
Shareholders
Proportion
Other
100.00%
Shareholder Types
Shareholders
Proportion
Other
100.00%
Institutional Shareholding
Updated: Tue, Jul 1
Updated: Tue, Jul 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
37
4.65M
0.00%
-1.67M
2025Q1
39
4.65M
0.00%
-1.97M
2024Q4
43
4.69M
0.00%
-1.58M
2024Q3
48
4.17M
0.00%
-3.35M
2024Q2
51
5.25M
0.00%
-2.85M
2024Q1
51
5.40M
0.00%
-2.75M
2023Q4
50
6.03M
0.00%
-2.17M
2023Q3
48
6.46M
0.00%
-1.82M
2023Q2
48
6.55M
0.00%
-1.56M
2023Q1
46
6.68M
0.00%
+1.09M
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Whitebox Advisors, L.L.C.
125.00K
0%
--
--
Mar 31, 2025
D. E. Shaw & Co., L.P.
100.00K
0%
--
--
Mar 31, 2025
Saba Capital Management, L.P.
97.30K
0%
--
--
Mar 31, 2025
Walleye Capital LLC
95.03K
0%
--
--
Mar 31, 2025
Cantor Fitzgerald, L.P
76.93K
0%
--
--
Mar 31, 2025
Clear Street LLC
47.62K
0%
-544.00
-1.13%
Mar 31, 2025
Skyview Investment Advisors, LLC
12.21K
0%
--
--
Dec 31, 2024
Ancora Advisors, L.L.C.
5.05K
0%
--
--
Mar 31, 2025
HGC Investment Management Inc.
5.00K
0%
--
--
Mar 31, 2025
View more
Related ETFs
Name
Proportion
No Data
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
